These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5806303)

  • 1. A method for the determination of neuraminidase activity in the presence of added neuraminic acids or potential inhibitors.
    Holmquist L
    Acta Chem Scand; 1969; 23(3):1045-52. PubMed ID: 5806303
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of the action of Vibrio cholerae sialidase on mammalian brain gangliosides by ionic strength.
    Lipovac V; Barton N; Rosenberg A
    Biochemistry; 1973 May; 12(10):1858-61. PubMed ID: 4704472
    [No Abstract]   [Full Text] [Related]  

  • 3. [2-Deoxy-2,3-dehydrosialic acids. II. Competitive inhibition of Vibrio cholerae neuraminidase by 2-deoxy-2,3-dehydro-N-acylneuraminic acids].
    Meindl P; Tuppy H
    Hoppe Seylers Z Physiol Chem; 1969 Sep; 350(9):1088-92. PubMed ID: 5349377
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulation of the production of neuraminidase in Vibrio cholerae cultures by N-acetylneuraminic acid and sialyl-lactose.
    FRENCH EL; ADA GL
    J Gen Microbiol; 1959 Dec; 21():550-60. PubMed ID: 13824857
    [No Abstract]   [Full Text] [Related]  

  • 5. Human placental alkaline phosphatase; a sialoprotein.
    Ghosh NK; Goldman SS; Fishman WH
    Enzymologia; 1967 Aug; 33(2):113-24. PubMed ID: 4317151
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuraminidase action on the human urinary glycoprotein of Tamm and Horsfall.
    Pape L; Maxfield M
    Biochim Biophys Acta; 1967 Apr; 133(3):574-81. PubMed ID: 6068546
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures.
    Lundgren G; Simmons RL
    Clin Exp Immunol; 1971 Dec; 9(6):915-26. PubMed ID: 4110358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of neuraminidase and acylneuraminate pyruvate lyase in a strain of vibrio falling into Heiberg's group II isolated from a patient with diarrhea.
    Müller HE
    Infect Immun; 1973 Sep; 8(3):430-3. PubMed ID: 4729932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential release of sialic acid from normal and malignant cells by Vibrio cholerae neuraminidase or influenza virus neuraminidase.
    Ray RK; Simmons RL
    Cancer Res; 1973 May; 33(5):936-9. PubMed ID: 4703124
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of neuraminidase with neuraminic acid C-glycosides.
    Wang Q; Wolff M; Polat T; Du Y; Linhardt RJ
    Bioorg Med Chem Lett; 2000 May; 10(9):941-4. PubMed ID: 10853664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the specificity of neuraminidase. Synthesis of benzyl 5-acetamido-3,5-dideoxy-beta-L-arabino-heptulosidaric acid, an a-ketosidic dicarboxylic derivative of N-acetyl-D-neuraminic acid resistant to Vibrio cholerae neuraminidase.
    Brossmer R; Holmquist L
    FEBS Lett; 1974 Apr; 40(2):250-2. PubMed ID: 4853464
    [No Abstract]   [Full Text] [Related]  

  • 12. Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment.
    Bekesi JG; St-Arneault G; Holland JF
    Cancer Res; 1971 Dec; 31(12):2130-2. PubMed ID: 5120303
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of gangliosides, sialomucopolysaccharides & fibrinogen as substrates for Vibrio cholaerae sialidase.
    Balasubramanian AS
    Indian J Biochem; 1971 Jun; 8(2):77-82. PubMed ID: 4259435
    [No Abstract]   [Full Text] [Related]  

  • 14. Properties of carbohydrate-stripped thyroglobulin. I. Preparation and physicochemical properties of desialized thyroglobulin.
    Tarutani O; Shulman S
    Biochim Biophys Acta; 1971 Mar; 229(3):642-8. PubMed ID: 5555216
    [No Abstract]   [Full Text] [Related]  

  • 15. Is divalent iron bound to transferrin?
    Gaber BP; Aisen P
    Biochim Biophys Acta; 1970 Nov; 221(2):228-33. PubMed ID: 5490230
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in splitting capacity of virus and V. cholerae neuraminidases on sialic acid type substrates.
    Drzeniek R
    Biochem Biophys Res Commun; 1967 Mar; 26(6):631-8. PubMed ID: 6030973
    [No Abstract]   [Full Text] [Related]  

  • 17. Removal of neuraminic acid from H-2 alloantigens without effect of antigenic reactivity.
    Shimada A; Nathenson SG
    J Immunol; 1971 Oct; 107(4):1197-9. PubMed ID: 5093779
    [No Abstract]   [Full Text] [Related]  

  • 18. Inability of isoquinoline derivatives to inhibit virus neuraminidase activity.
    Shinkai K; Nishimura T
    J Gen Virol; 1972 Aug; 16(2):227-9. PubMed ID: 5072367
    [No Abstract]   [Full Text] [Related]  

  • 19. The binding of exogenously added neuraminidase to cells and tissues in culture.
    McQuiddy P; Lilien JE
    Biochim Biophys Acta; 1973 Feb; 291(3):774-9. PubMed ID: 4735233
    [No Abstract]   [Full Text] [Related]  

  • 20. [Occurrence of neuraminidase and Acylneuraminate Lyase in NAG vibrios (author's transl)].
    Müller HE; Lütticken R
    Pathol Microbiol (Basel); 1974; 41(5):233-9. PubMed ID: 4444832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.